Competition explodes amid weight loss drug shortage
By The Hill | Created at 2024-09-25 17:07:18 | Updated at 2024-09-30 17:29:39
5 days ago
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth companies look to tap into the fast-growing industry. GLP-1 medications like Ozempic and Mounjaro have become highly popular for their ability to aid weight loss. According to…
